Zhishen Ye

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Matthew R. Smith, Fred Saad, Robert E. Coleman et al. · The Lancet · 2011 · 792 citations · Full text

Urology, Oncology, Genitourinary Cancer +6

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

David M. Thomas, Robert M. Henshaw, Keith M. Skubitz et al. · The Lancet Oncology · 2010 · 703 citations

Bone Disease, Malignant Disease, Medicine +7

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

Matthew R. Smith, Fred Saad, Stéphane Oudard et al. · Journal of Clinical Oncology · 2013 · 247 citations · Full text

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

Pasi A. Jänne, Antoinette J. Wozniak, Chandra P. Belani et al. · Clinical Lung Cancer · 2005 · 209 citations

Surgical Oncology, Medicine, Cancer Management +7

The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection

Edward Gane, Young‐Suk Lim, Stuart C. Gordon et al. · Journal of Hepatology · 2015 · 183 citations

Autoimmune Disease, Hepatology, Viral Hepatitis +9